This work was funded in part by the Division of Intramural Research of the National Institute of Environmental Health Sciences
Do not start, stop, or change any medication without speaking to your healthcare provider
Pre-existing conditions that increase risk Researchers with the following conditions should discuss retatrutide heart rate effects with their physician before starting a protocol: History of atrial fibrillation or other arrhythmias - the increased contractile force and rate from glucagon receptor activation could potentially trigger or worsen existing rhythm disorders Heart failure - while increased contractility might seem beneficial, the increased cardiac workload from higher heart rate can worsen heart failure in some cases Hyperthyroidism - thyroid hormone excess already increases heart rate, and adding retatrutide could produce additive effects Anxiety disorders or panic disorder - heightened awareness of cardiac sensations can trigger anxiety episodes in susceptible individuals Use of stimulant medications - amphetamines, methylphenidate, and similar drugs increase heart rate through sympathetic activation, and combining them with retatrutide glucagon receptor effects could produce larger-than-expected increases For most healthy adults without these conditions, a gradual dose escalation starting at lower doses allows the cardiovascular system to adapt and minimizes the risk of abrupt, uncomfortable heart rate changes
In other words, a patient must fail or be intolerant to a first-line (often generic) medication before the insurer will cover the higher-cost alternative
The conservation of the orthologs to GSTE14 in other insects attests to an essential function, which merits further biochemical investigations
